Search - tctmd.com

Displaying 81 - 100 of 179

Sort: Relevancy | Date

News Daily News

American College of Cardiology Steps Up: Equal Pay, Opportunities for All

Caitlin E. Cox

September 17, 2019

News Conference News HFSA 2019

DEFINE-HF: Dapagliflozin Improves Function and QoL, but Not Biomarkers, in HFrEF

L.A. McKeown

September 16, 2019

News Conference News ESC 2019

New PURE Insights: CVD Deaths Dip in Rich Nations Amid Risk-Factor Surprises

Michael O'Riordan

September 04, 2019

ORION-11: Inclisiran Shows Promise, Safety in Largest Published Cohort

News Conference News ESC 2019

ORION-11: Inclisiran Shows Promise, Safety in Largest Cohort to Date

Yael L. Maxwell

September 03, 2019

News Conference News ESC 2019

Nonphysician, Community Intervention Curbs CV Risk Factors: HOPE 4

Michael O'Riordan

September 02, 2019

News Conference News ESC 2019

Supplemental Oxygen Fails Once Again in ACS Patients: NZOTACS

Michael O'Riordan

September 01, 2019

News Conference News ESC 2019

COMPLETE Beats Culprit-Only PCI in Multivessel STEMI and Timing Doesn’t Matter

Yael L. Maxwell

September 01, 2019

News Opinion Off Script

#Selfies, Carrots, and Push-ups: A Defense of Social Media in Modern-Day Medicine

Mamas Mamas, BMBCh

August 23, 2019

News Conference News ESC 2019

ESC 2019: Antiplatelets in Diabetes, CAD and A-fib, an ARNI in HFpEF, Staged Complete PCI, and More

Shelley Wood

August 22, 2019

News Daily News

FDA Expands TAVR Indication to Low-Risk Patients

Michael O'Riordan

August 16, 2019

News Daily News

Ideal CV Health at Age 50 Foretells Lower Risk of Later Dementia

Marcus A. Banks

August 12, 2019

News Daily News

CTO PCI Consensus Document Aims for Quality, Consistency but Acknowledges Data Gaps

Yael L. Maxwell

August 08, 2019

News Daily News

FDA Gives Eagerly Awaited Update on Mortality With Paclitaxel-Coated Devices in PAD

Todd Neale

August 07, 2019

News Daily News

TAVR Bleeds Stand Apart From PCI-Related Events

Caitlin E. Cox

August 06, 2019

News Daily News

Best Strategy Questioned for NSTE ACS Patients With Prior CABG

Shelley Wood

August 05, 2019

News Opinion Conversations in Cardiology

Conversations in Cardiology: The Push for High-Sensitivity Troponin

August 02, 2019

News Daily News

TCTMD’s Top 10 Most Popular Stories for July 2019

Shelley Wood

July 31, 2019

News Opinion Off Script

Off Script: Through ‘Paclitaxelgate,’ Some Upsides to Uncertainty

Sahil Parikh, MD

July 29, 2019

News Daily News

Adherence to US Physical Activity Guidance Flattens as Sedentary Time Creeps Up

Shelley Wood

July 26, 2019

News Daily News

Thwarted Access to PCSK9 Inhibitors Linked to Greater Risk of Major CV Events

Marcus A. Banks

July 25, 2019

Advertisement

American College of Cardiology Steps Up: Equal Pay, Opportunities for All

DEFINE-HF: Dapagliflozin Improves Function and QoL, but Not Biomarkers, in HFrEF

New PURE Insights: CVD Deaths Dip in Rich Nations Amid Risk-Factor Surprises

ORION-11: Inclisiran Shows Promise, Safety in Largest Cohort to Date

Nonphysician, Community Intervention Curbs CV Risk Factors: HOPE 4

Supplemental Oxygen Fails Once Again in ACS Patients: NZOTACS

COMPLETE Beats Culprit-Only PCI in Multivessel STEMI and Timing Doesn’t Matter

#Selfies, Carrots, and Push-ups: A Defense of Social Media in Modern-Day Medicine

ESC 2019: Antiplatelets in Diabetes, CAD and A-fib, an ARNI in HFpEF, Staged Complete PCI, and More

FDA Expands TAVR Indication to Low-Risk Patients

Ideal CV Health at Age 50 Foretells Lower Risk of Later Dementia

CTO PCI Consensus Document Aims for Quality, Consistency but Acknowledges Data Gaps

FDA Gives Eagerly Awaited Update on Mortality With Paclitaxel-Coated Devices in PAD

TAVR Bleeds Stand Apart From PCI-Related Events

Best Strategy Questioned for NSTE ACS Patients With Prior CABG

Conversations in Cardiology: The Push for High-Sensitivity Troponin

TCTMD’s Top 10 Most Popular Stories for July 2019

Off Script: Through ‘Paclitaxelgate,’ Some Upsides to Uncertainty

Adherence to US Physical Activity Guidance Flattens as Sedentary Time Creeps Up

Thwarted Access to PCSK9 Inhibitors Linked to Greater Risk of Major CV Events

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content